???pagination.result.count???
Detection of substance P in the central nervous system by a monoclonal antibody. , Cuello AC, Galfre G, Milstein C., Proc Natl Acad Sci U S A. July 1, 1979; 76 (7): 3532-6.
Substance P-related peptides in the hypothalamus of amphibia. , Gaudino G, Fasolo A., Cell Tissue Res. January 1, 1980; 211 (2): 241-50.
Differentiating effects of murine nerve growth factor in the peripheral and central nervous systems of Xenopus laevis tadpoles. , Levi-Montalcini R, Aloe L., Proc Natl Acad Sci U S A. October 1, 1985; 82 (20): 7111-5.
Neurotensin and substance P receptors expressed in Xenopus oocytes by messenger RNA from rat brain. , Parker I, Sumikawa K, Miledi R ., Proc R Soc Lond B Biol Sci. November 22, 1986; 229 (1255): 151-9.
Induction of muscarinic acetylcholine, serotonin and substance P receptors in Xenopus oocytes injected with mRNA prepared from the small intestine of rats. , Aoshima H, Iio H, Anan M, Ishii H, Kobayashi S., Dev Biol. April 1, 1987; 388 (1): 15-20.
Development of substance P-like immunoreactivity in Xenopus embryos. , Gallagher BC, Moody SA ., J Comp Neurol. June 8, 1987; 260 (2): 175-85.
Expression of two different tachykinin receptors in Xenopus oocytes by exogenous mRNAs. , Harada Y , Takahashi T, Kuno M, Nakayama K, Masu Y, Nakanishi S., J Neurosci. October 1, 1987; 7 (10): 3265-73.
cDNA cloning of bovine substance-K receptor through oocyte expression system. , Masu Y, Nakayama K, Tamaki H, Harada Y , Kuno M, Nakanishi S., Nature. October 29, 1987; 329 (6142): 836-8.
Morphological characterization of substance P-like immunoreactive amacrine cells in the anuran retina. , Hiscock J, Straznicky C., Vision Res. January 1, 1989; 29 (3): 293-301.
Neurohormonal regulation of ion transport in the porcine distal jejunum. Actions of neurotensin and its natural homologs. , Brown DR, Treder BG., J Pharmacol Exp Ther. April 1, 1989; 249 (1): 348-57.
Molecular characterization of a functional cDNA for rat substance P receptor. , Yokota Y, Sasai Y , Tanaka K, Fujiwara T, Tsuchida K, Shigemoto R, Kakizuka A, Ohkubo H, Nakanishi S., J Biol Chem. October 25, 1989; 264 (30): 17649-52.
Cloning and expression of a rat neuromedin K receptor cDNA. , Shigemoto R, Yokota Y, Tsuchida K, Nakanishi S., J Biol Chem. January 15, 1990; 265 (2): 623-8.
Calcium wave evoked by activation of endogenous or exogenously expressed receptors in Xenopus oocytes. , Brooker G, Seki T, Croll D, Wahlestedt C., Proc Natl Acad Sci U S A. April 1, 1990; 87 (7): 2813-7.
Neuropeptide Y- and substance P-like immunoreactive amacrine cells in the retina of the developing Xenopus laevis. , Hiscock J, Straznicky C., Brain Res Dev Brain Res. June 1, 1990; 54 (1): 105-13.
Cloning and functional characterization of a complementary DNA encoding the murine fibroblast bombesin/ gastrin-releasing peptide receptor. , Spindel ER , Giladi E, Brehm P, Goodman RH, Segerson TP., Mol Endocrinol. December 1, 1990; 4 (12): 1956-63.
Molecular and genetic characterization, functional expression, and mRNA expression patterns of a rat substance P receptor. , Hershey AD, Polenzani L, Woodward RM, Miledi R , Krause JE., Ann N Y Acad Sci. January 1, 1991; 632 63-78.
Strategies to detect heterologously expressed tachykinin receptors in Xenopus Oocytes. , Wahlestedt C., Ann N Y Acad Sci. January 1, 1991; 632 116-22.
Localization of substance P, CGRP, VIP, neuropeptide Y, and somatostatin immunoreactive nerve fibers in the carotid labyrinths of some amphibian species. , Kusakabe T, Anglade P, Tsuji S., Histochemistry. January 1, 1991; 96 (3): 255-60.
Pharmacology of neurokinin receptors. , Regoli D, Nantel F., Biopolymers. May 1, 1991; 31 (6): 777-83.
Isolation and characterisation of the human lung NK-2 receptor gene using rapid amplification of cDNA ends. , Graham A, Hopkins B, Powell SJ, Danks P, Briggs I., Biochem Biophys Res Commun. May 31, 1991; 177 (1): 8-16.
Isolation and characterisation of the human lung NK-1 receptor cDNA. , Hopkins B, Powell SJ, Danks P, Briggs I, Graham A., Biochem Biophys Res Commun. October 31, 1991; 180 (2): 1110-7.
Cloning, heterologous expression and developmental regulation of a Drosophila receptor for tachykinin-like peptides. , Li XJ, Wolfgang W, Wu YN, North RA, Forte M., EMBO J. November 1, 1991; 10 (11): 3221-9.
A peptide-hormone-inactivating endopeptidase in Xenopus laevis skin secretion. , Carvalho KM, Joudiou C, Boussetta H, Leseney AM, Cohen P., Proc Natl Acad Sci U S A. January 1, 1992; 89 (1): 84-8.
Differential activation of intracellular effector by two isoforms of human neurokinin-1 receptor. , Fong TM, Anderson SA, Yu H, Huang RR, Strader CD., Mol Pharmacol. January 1, 1992; 41 (1): 24-30.
Cloning, functional expression, and developmental regulation of a neuropeptide Y receptor from Drosophila melanogaster. , Li XJ, Wu YN, North RA, Forte M., J Biol Chem. January 5, 1992; 267 (1): 9-12.
Molecular cloning of the murine substance K and substance P receptor genes. , Sundelin JB, Provvedini DM, Wahlestedt CR, Laurell H, Pohl JS, Peterson PA., Eur J Biochem. February 1, 1992; 203 (3): 625-31.
cDNA sequence and heterologous expression of the human neurokinin-3 receptor. , Huang RR, Cheung AH, Mazina KE, Strader CD, Fong TM., Biochem Biophys Res Commun. April 30, 1992; 184 (2): 966-72.
Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. , Fong TM, Huang RR, Strader CD., J Biol Chem. December 25, 1992; 267 (36): 25664-7.
Desensitization of human endothelin A receptor. , Cyr C, Kris RM., J Cardiovasc Pharmacol. January 1, 1993; 22 Suppl 8 S11-4.
A Xenopus homebox gene defines dorsal- ventral domains in the developing brain. , Saha MS , Michel RB, Gulding KM, Grainger RM ., Development. May 1, 1993; 118 (1): 193-202.
Characterization of the thermolysin-like cleavage of biologically active peptides by Xenopus laevis peptide hormone inactivating enzyme. , Joudiou C, Carvalho KM, Camarao G, Boussetta H, Cohen P., Biochemistry. June 15, 1993; 32 (23): 5959-66.
mRNAs coding for neurotransmitter receptors in rabbit and rat visual areas. , Matute C, Nguyen QT, Miledi R ., J Neurosci Res. August 15, 1993; 35 (6): 652-63.
Amyloid beta-protein activates tachykinin receptors and inositol trisphosphate accumulation by synergy with glutamate. , Kimura H, Schubert D., Proc Natl Acad Sci U S A. August 15, 1993; 90 (16): 7508-12.
Human neuroblastoma cells express a novel metallo-endopeptidase activity able to inactivate atrial natriuretic factor: inhibition during retinoic acid-induced differentiation. , Carvalho KM, De-Laurenzi V, Melino G, Cohen P., Braz J Med Biol Res. November 1, 1993; 26 (11): 1181-6.
Prolonged desensitization of the human endothelin A receptor in Xenopus oocytes. Comparative studies with the human neurokinin A receptor. , Cyr CR, Rudy B, Kris RM., J Biol Chem. December 15, 1993; 268 (35): 26071-4.
Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA. , Aharony D, Little J, Thomas C, Powell S, Berry D, Graham A., Mol Pharmacol. January 1, 1994; 45 (1): 9-19.
The beta subunit of neuronal nicotinic acetylcholine receptors is a determinant of the affinity for substance P inhibition. , Stafford GA, Oswald RE, Weiland GA., Mol Pharmacol. April 1, 1994; 45 (4): 758-62.
Attenuation of agonist-induced desensitization of the rat substance P receptor by progressive truncation of the C-terminus. , Sasakawa N, Sharif M, Hanley MR., FEBS Lett. June 27, 1994; 347 (2-3): 181-4.
Attenuation of agonist-induced desensitization of the rat substance P receptor by microinjection of inositol pentakis-and hexakisphosphates in Xenopus laevis oocytes. , Sasakawa N, Ferguson JE, Sharif M, Hanley MR., Mol Pharmacol. August 1, 1994; 46 (2): 380-5.
tinman, a Drosophila homeobox gene required for heart and visceral mesoderm specification, may be represented by a family of genes in vertebrates: XNkx-2.3, a second vertebrate homologue of tinman. , Evans SM, Yan W, Murillo MP, Ponce J, Papalopulu N ., Development. November 1, 1995; 121 (11): 3889-99.
A single mutation of the neurokinin-2 ( NK2) receptor prevents agonist-induced desensitization. Divergent conformational requirements for NK2 receptor signaling and agonist-induced desensitization in Xenopus oocytes. , Nemeth K, Chollet A., J Biol Chem. November 17, 1995; 270 (46): 27601-5.
Heterologous desensitization of the human endothelin A and neurokinin A receptors in Xenopus laevis oocytes. , Cyr CR, Devi LA, Rudy B, Kris RM., Recept Signal Transduct. January 1, 1996; 6 (2): 99-109.
Probing the structure and function of the tachykinin neurokinin-2 receptor through biosynthetic incorporation of fluorescent amino acids at specific sites. , Turcatti G, Nemeth K, Edgerton MD, Meseth U, Talabot F, Peitsch M, Knowles J, Vogel H, Chollet A., J Biol Chem. August 16, 1996; 271 (33): 19991-8.
The atrial natriuretic factor promoter is a downstream target for Nkx-2.5 in the myocardium. , Durocher D, Chen CY , Ardati A, Schwartz RJ, Nemer M., Mol Cell Biol. September 1, 1996; 16 (9): 4648-55.
Functional characterization by heterologous expression of a novel cloned tachykinin peptide receptor. , Donaldson LF, Haskell CA, Hanley MR., Biochem J. November 15, 1996; 320 ( Pt 1) 1-5.
Fluorescent labeling of NK2 receptor at specific sites in vivo and fluorescence energy transfer analysis of NK2 ligand-receptor complexes. , Turcatti G, Nemeth K, Edgerton MD, Knowles J, Vogel H, Chollet A., Recept Channels. January 1, 1997; 5 (3-4): 201-7.
The cardiac transcription factors Nkx2-5 and GATA-4 are mutual cofactors. , Durocher D, Charron F, Warren R, Schwartz RJ, Nemer M., EMBO J. September 15, 1997; 16 (18): 5687-96.
Vertebrate homologs of tinman and bagpipe: roles of the homeobox genes in cardiovascular development. , Tanaka M, Kasahara H, Bartunkova S, Schinke M, Komuro I, Inagaki H, Lee Y , Lyons GE, Izumo S., Dev Genet. January 1, 1998; 22 (3): 239-49.
Basal ganglia organization in amphibians: chemoarchitecture. , Marín O, Smeets WJ , González A ., J Comp Neurol. March 16, 1998; 392 (3): 285-312.
The relationship between the agonist-induced activation and desensitization of the human tachykinin NK2 receptor expressed in Xenopus oocytes. , Maudsley S, Gent JP, Findlay JB, Donnelly D., Br J Pharmacol. June 1, 1998; 124 (4): 675-84.